Short Interest in Elevai Labs, Inc. (NASDAQ:ELAB) Decreases By 44.6%

Elevai Labs, Inc. (NASDAQ:ELAB) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 185,700 shares, a decrease of 44.6% from the January 31st total of 335,000 shares. Based on an average daily trading volume, of 2,210,000 shares, the short-interest ratio is presently 0.1 days.

Elevai Labs Stock Down 2.8 %

Shares of ELAB opened at $1.21 on Tuesday. The company has a quick ratio of 3.40, a current ratio of 3.86 and a debt-to-equity ratio of 0.06. The business has a fifty day moving average of $1.97 and a 200 day moving average of $16.58. The company has a market cap of $4.89 million, a PE ratio of -0.02 and a beta of -3.28. Elevai Labs has a 52-week low of $1.16 and a 52-week high of $165.96.

Elevai Labs Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.